Skip to main content

Table 1 Patients profiles

From: A Phase I clinical trial of EUS-guided intratumoral injection of the oncolytic virus, HF10 for unresectable locally advanced pancreatic cancer

Patient no. Age Contents (p.f.u) X Time Injection site Staginga (radiological) Staginga (postoperative)
Cohort 1 HF-1-02 60s 1X106X4 Pancreas head III (T4N0M0) NA
HF-1-04 60s 1X106X4 Pancreas head (uncinate process) III (T4N0M0) NA
HF-1-05 60s 1X106X4 Pancreas body III (T4N0M0) IIA (T3N0M0)
Cohort 2 HF-2-01 60s 3X106X4 Pancreas body III (T4N0M0) NA
HF-2-02 60s 3X106X4 Pancreas head (uncinate process) III (T4N0M0) IIA (T3N0M0)
HF-2-03 60s 3X106X4 Pancreas body III (T4N0M0) NA
Cohort 3 HF-3-01 60s 1X107X3 Pancreas body III (T4N0M0) NA
HF-3-02 50s 1X107X4 Pancreas head (uncinate process) III (T4N0M0) NA
HF-3-03 60s 1X107X4 Pancreas body III (T4N0M0) NA
HF-3-04 60s 1X107X4 Pancreas head III (T4N0M0) NA
  1. aBased on NCCN Clinical Practice Guidelines in Oncology [13]
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us